Soler-Palacín P., Margareto C., Llobet P., et al., Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr), 2007;35: 83-89.
2.
Lakshman R., Finn A.Neutrophil disorders and their management. J Clin Pathol. 2001;54:7-19.
3.
van den Berg JM, van Koppen E., Ahlin A., et al. Chronic granulomatous disease: the European experience. PLoS One, 2009;4(4):e5234.
4.
Winkelstein JA, Marino MC, Johnston RB Jr, et al., Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine ( Baltimore). 2000;79: 155-169.
5.
Galluzzo ML, Hernandez C., Davila MT, et al. Clinical and histopathological features and a unique spectrum of organisms significantly associated with chronic granulomatous disease osteomyelitis during childhood. Clin Infect Dis. 2008;46:745-749.
6.
Ma JS, Chen PY, Fu LS, et al. Chronic granulomatous disease: a case report. J Microbiol Immunol Infect. 2000;33: 118-122.
7.
Vowells SJ, Sekhsaria S., Malech HL, Shalit M., Fleisher TAFlow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods. 1995;178:89-97.
8.
Weening RS, Kabel P., Pijman P., Roos D.Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J Pediatr. 1983;103:127-130.
9.
Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348:2416-2422.
10.
A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med. 1991;324:509-516.
11.
Seger RA, Gungor T., Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood. 2002;100: 4344-4350.
